Pharmafile Logo
Pharmafocus logo
Advanced Search
nice_reception_manc_3_2_1

NICE recommends at-home treatment for spinal muscular atrophy

November 19, 2021
Medical Communications

NICE has recommended risdiplam as treatment for the rare genetic disorder, spinal muscular atrophy, as part of a managed access …

News

Crohn’s patients see 65% remission in clinical trial

November 18, 2021
Business Services

Janssen has announced topline results from the Phase II GALAXI 1 clinical which showed rates of clinical remission previously reported …

News

NIAID and Children’s National Hospital begin long-term study of children with COVID-19

November 18, 2021
Business Services

The National Institutes of Health has commenced a long-term investigation into the impacts of COVID-19 in children. The study, supported …

News

AstraZeneca COVID-19 antibody drug offers 83% protection over six month period

November 18, 2021
Business Services

New data from AstraZeneca’s COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials have revealed high efficacy from a …

News

NICE recommends Opdivo (nivolumab) for oesophageal cancer treatment

November 17, 2021
Research and Development

NICE has recommended nivolumab for the adjuvant treatment of completely resected oesophageal or gastro-oesophageal junction (GOJ) cancer, in adults who …

News

Health experts warn of a ‘hidden pandemic’ of antibiotic-resistant infections

November 17, 2021
Research and Development

UK health officials have warned that a ‘hidden pandemic’ of antibiotic-resistant infections could occur if people take antibiotics to fight …

News

Pfizer deal allows generic versions of COVID pill for low-income countries

November 17, 2021
Research and Development

Pfizer has announced a deal for the production of its antiviral Paxlovid pill to generic drug manufactures, for supply in …

News

US secures over 750,000 doses of GSK-Vir COVID-19 drug

November 17, 2021
Research and Development

The US has secured GSK and Vir Biotechnology’s antibody-based COVID-19 treatment, through signing contracts worth approximately $1 billion, according to …

News

Orexo’s new drug effective against opioid overdoses

November 16, 2021
Manufacturing and Production

Orexo announced it has successfully completed the trial for its lead pharmaceutical pipeline asset, OX124, designed to help patients in …

News

Moderna announce promising study in mRNA drug for heart failure

November 16, 2021
Manufacturing and Production

The biotechnology company Moderna have announced positive data from the AstraZeneca-led Phase IIa EPICCURE trial, evaluating the use of a …

News

Revelar Biotherapeutics launches for development of COVID-19 and other antibody therapeutics

November 16, 2021
Manufacturing and Production

Twist Bioscience Corporation announced that it has launched Revelar Biotherapeutics, an independently operated, new biotechnology company to develop and commercialise …

News

Arrowhead Collaboration presents Phase IIb data from Hepatitis B study

November 16, 2021
Manufacturing and Production

Arrowhead Pharmaceuticals Inc collaborator, Janssen Pharmaceuticals Inc, have presented clinical data from REEF-1, a Phase IIb study of different combination …

News

Emergex trial new form of COVID vaccine

November 15, 2021
Sales and Marketing

Emergex, an Oxfordshire based company, is moving towards Phase I trials for its novel COVID-19 vaccine, which is applied as …

News
11347696326_bac61dbf66_e

Theramex launches Femarelle to treat menopause symptoms

November 15, 2021
Sales and Marketing

Theramex recently announced that they have acquired the Femarelle ® product licence to treat menopause symptoms. The commercialisation agreement was reached …

News

Pfizer vaccine generates most antibodies, comparative study suggests

November 15, 2021
Sales and Marketing

Pfizer Inc. and BioNTech’s COVID-19 vaccine yielded the strongest immune response in a comparative study of four vaccines. The study, …

News

First patient dosed in tumour membrane immunotherapy trial

November 15, 2021
Sales and Marketing

Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumour membrane immunotherapy, announced that …

News

Biogen’s Aduhelm shown to reduce clinical decline in Alzheimer’s disease

November 12, 2021
Medical Communications

New ADUHELM (aducanumab-avwa) Phase III data has shown a positive correlation between plasma p-tau reduction and less cognitive and functional …

News

Blood pressure drugs could protect against type 2 diabetes

November 12, 2021
Medical Communications

Researchers have found that blood pressure drugs may directly reduce people’s risk of type 2 diabetes, a condition that an …

News
mat-napo-pij34zrzeew-unsplash

Trial investigates whether immunosuppressant holiday boosts vaccine protection

November 12, 2021
Medical Communications

A trial has been launched to evaluate how to increase COVID-19 vaccine protection among vulnerable patients taking immunosuppressant drugs . …

News

Kintor Pharma begins Phase II trial of KX-826 for androgenetic alopecia treatment

November 12, 2021
Medical Communications

Kintor Pharma, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026